• Profile
Close

Regular use of proton pump inhibitors and risk of type 2 diabetes: Results from three prospective cohort studies

Gut May 12, 2021

Yuan J, He Q, Nguyen LH, et al. - Researchers undertook this prospective study of 204,689 participants free of diabetes in the Nurses' Health Study (NHS), NHS II and Health Professionals Follow-up Study, to examine whether regular use of proton pump inhibitors (PPIs) is associated with the risk of type 2 diabetes. They assessed hazard ratios adjusting for demographic factors, lifestyle habits, the presence of comorbidities, employment of other medications and clinical indications. Findings revealed a higher risk of type 2 diabetes in relation to regular use of PPIs, and the risk was shown to elevate with longer duration of use. Thus, clinicians are advised to exercise caution when prescribing PPIs, especially for long-term use.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay